Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant [2]

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 6, 2001, Pages 818-

  Zarranz, J J ^a   Rouco, I ^a   Gomez Esteban, J C ^a   Corral, J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LETTER; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PREVALENCE; PRIORITY JOURNAL; SPINAL CORD DISEASE; SUBACUTE MYELOPATHY; VIRUS INFECTION;

ADULT; CARCINOMA, HEPATOCELLULAR; ENDEMIC DISEASES; FEMALE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; PARAPARESIS, TROPICAL SPASTIC; REGISTRIES; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SPAIN; TISSUE DONORS;

EID: 0035208845     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.6.818     Document Type: Letter

References (5)

1. Human T-lymphotropic virus type I infection
2. Rapid development of myelopathy after HTLV-1 infection acquired by transfusion during cardiac transplantation
3. Interferon-alpha is effective in HTLV-1 associated myelopathy: A multicenter, randomized, double-blind, controlled trial
4. Infección por HTLV-1 en España. Análisis de 24 casos identificados hasta Noviembre de 1994
5. Influence of inmunosupresion in HTLV-1-positive renal transplant recipients